Photodynamic therapy with methyl aminolaevulinate 80 mg g-1 for severe facial acne vulgaris: A randomized vehicle-controlled study

British Journal of Dermatology

Volumn 174, Issue 4, 2016, Pages 770-777

  Pariser, D M ^a   Eichenfield, L F ^b   Bukhalo, M ^c   Waterman, G ^d   Jarratt, M ^e   Bhatia, A ^f   Greenstein, D ^f   Hamzavi, F ^f   Kantor, J ^f   Speelman, P N ^f   Murakawa, G J ^f   Tichy, E ^f   Zaengelin, A ^f   Frankel, E ^f   Werschler, W ^f  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Altman Dermatology Associates   (United States)

^d Deaconess Clinic   (United States)

^e DermResearch Inc   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; AMINOLEVULINIC ACID; METHYL 5-AMINOLEVULINATE; OINTMENT; PHOTOSENSITIZING AGENT;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HUMAN; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RED LIGHT; RISK ASSESSMENT; SCAR FORMATION; SKIN BURNING SENSATION; VISUAL ANALOG SCALE; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CHILD; CLINICAL TRIAL; CUTANEOUS DRUG ADMINISTRATION; DRUG ERUPTIONS; FACIAL DERMATOSES; OINTMENT; PHOTOCHEMOTHERAPY; PROCEDURES; TREATMENT OUTCOME; YOUNG ADULT;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AMINOLEVULINIC ACID; CHILD; DOUBLE-BLIND METHOD; DRUG ERUPTIONS; FACIAL DERMATOSES; FEMALE; HUMANS; MALE; OINTMENTS; PAIN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84959432553     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14345     Document Type: Article

References (25)

1. Bhate K, Williams HC,. Epidemiology of acne vulgaris. Br J Dermatol 2013; 168: 474-85.
2. Gollnick H,. Current concepts of the pathogenesis of acne: implications for drug treatment. Drugs 2003; 63: 1579-96.
3. Thiboutot D, Gollnick H, Bettoli V, et al,. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne Group. J Am Acad Dermatol 2009; 60 (5 Suppl.): S1-50.
4. Eichenfield LF, Krakowski AC, Piggott C, et al,. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics 2013; 131 (Suppl. 3): S163-86.
5. Strauss JS, Krowchuk DP, Leyden JJ, et al,. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007; 56: 651-63.
6. Nast A, Dréno B, Bettoli V, et al,. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012; 26 (Suppl. 1): 1-29.
7. McLane J,. Analysis of common side-effects of isotretinoin. J Am Acad Dermatol 2001; 45: S188-94.
8. Sundström A, Alfredsson L, Sjölin-Forsberg G, et al,. Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. BMJ 2010; 341: c5812.
9. Langan SM, Batchelor JM,. Acne, isotretinoin and suicide attempts: a critical appraisal. Br J Dermatol 2011; 164: 1183-5.
10. Chia CY, Lane W, Chibnall J, et al,. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study. Arch Dermatol 2005; 141: 557-60.
11. Marqueling AL, Zane LT,. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg 2007; 26: 210-20.
12. Yentzer BA, Hick J, Reese EL, et al,. Acne vulgaris in the United States: a descriptive epidemiology. Cutis 2010; 86: 94-9.
13. Pollock B, Turner D, Stringer MR, et al,. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol 2004; 151: 616-22.
14. Hongcharu W, Taylor CR, Chang Y, et al,. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000; 115: 183-92.
15. Hörfelt C, Funk J, Frohm-Nilsson M, et al,. Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study. Br J Dermatol 2006; 155: 608-13.
16. Wiegell SR, Wulf HC,. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Br J Dermatol 2006; 154: 969-76.
17. Wiegell SR, Wulf HC,. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol 2006; 54: 647-51.
18. -1 without occlusion improves acne vulgaris. J Drugs Dermatol 2010; 9: 1347-52.
19. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). (2005) Guidance for industry. Acne vulgaris: developing drugs for treatment. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071292.pdf (last accessed 31 January 2016).
20. Dréno B, Bettoli V, Ochsendorf F, et al,. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations. Eur J Dermatol 2006; 16: 565-71.
21. Williams HC, Dellavalle RP, Garner S,. Acne vulgaris. Lancet 2012; 379: 361-72.
22. Sakamoto FH, Lopes JD, Anderson RR,. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice. Part 1. Acne vulgaris: when and why consider photodynamic therapy? J Am Acad Dermatol 2010; 63: 183-93.
23. Sakamoto FH, Lopes JD, Anderson RR,. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice. Part 2. Understanding parameters for acne treatment with photodynamic therapy. J Am Acad Dermatol 2010; 63: 195-211.
24. Hayashi N, Akamatsu H, Kawashima M,. Establishment of grading criteria for acne severity. J Dermatol 2008; 35: 255-60.
25. Lehmann HL, Robinson KA, Andrews JS, et al,. Acne therapy: a methodological review. J Am Acad Dermatol 2002; 47: 231-40.